| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,738 |
9,384 |
$393K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,142 |
7,118 |
$161K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,574 |
1,574 |
$117K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,165 |
1,144 |
$79K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
857 |
857 |
$64K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
854 |
836 |
$56K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,081 |
1,030 |
$53K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
330 |
330 |
$27K |
| 99441 |
|
646 |
595 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
509 |
474 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
125 |
125 |
$5K |
| 0071A |
|
108 |
108 |
$4K |
| 0072A |
|
99 |
99 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
372 |
370 |
$3K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
456 |
450 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
169 |
85 |
$3K |
| 96127 |
|
419 |
409 |
$2K |
| 0001A |
|
39 |
39 |
$1K |
| 0002A |
|
39 |
39 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
230 |
223 |
$1K |
| 90480 |
|
16 |
16 |
$500.00 |
| 87070 |
|
60 |
60 |
$482.36 |
| 0003A |
|
12 |
12 |
$463.92 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
12 |
12 |
$463.44 |
| 90686 |
|
1,612 |
1,608 |
$332.12 |
| 90688 |
|
304 |
304 |
$282.83 |
| 99442 |
|
12 |
12 |
$176.78 |
| 83655 |
|
12 |
12 |
$155.10 |
| 99177 |
|
123 |
123 |
$96.79 |
| 90656 |
|
33 |
33 |
$66.93 |
| 85018 |
|
12 |
12 |
$18.78 |
| 94760 |
|
25 |
25 |
$3.92 |
| 99072 |
|
1,434 |
1,396 |
$2.83 |
| 91300 |
|
123 |
114 |
$0.21 |
| 91307 |
|
250 |
215 |
$0.07 |
| 90670 |
|
246 |
246 |
$0.00 |
| 90461 |
|
186 |
186 |
$0.00 |
| 99080 |
|
339 |
337 |
$0.00 |
| 99499 |
|
301 |
301 |
$0.00 |
| 90685 |
|
26 |
26 |
$0.00 |
| 90633 |
|
14 |
14 |
$0.00 |
| 90671 |
|
13 |
13 |
$0.00 |
| 90698 |
|
275 |
275 |
$0.00 |
| 99000 |
|
874 |
854 |
$0.00 |
| 99070 |
|
111 |
108 |
$0.00 |
| 90680 |
|
65 |
65 |
$0.00 |
| 90744 |
|
13 |
13 |
$0.00 |